First gene-editing trial to start next month in China
The immune cells of lung cancer patients at a hospital in Chengdu, China, are to be modified using the powerful CRISPR-Cas9 gene editing technology so they can target the tumour.
Continue Reading http://www.dailymail.co.uk
Join the Discussion